Intrathecal catheterization is a highly effective delivery method for drugs targeting neurological diseases, writes Brad Gien, head of surgery, North America, E 17 October 2018
Initial public offerings (IPOs) are often seen as attractive by business owners in the life sciences or biotech field, writes Alan Wovsaniker, a partner with Lo 11 October 2018
Kevin Noonan, a partner with McDonnell Boehnen Hulbert & Berghoff, provides commentary on the US Food and Drug Administration's Biosimilars Action Plan in an Ex 4 October 2018
With CAR-T therapies closer than ever to delivering on their promise but still facing significant obstacles, Eva Marchese and Cécile Matthews from Charles River 24 September 2018
Supply chain imperatives are evolving from drug production and delivery that are limited in scope towards a versatile supply chain addressing the needs of multi 17 September 2018
In the first half of 2018, global equity markets experienced volatility. But, emerging markets, such as India and China, displayed a healthy resilience, even ou 11 September 2018
In an Expert View piece, Iain Barton, healthcare strategy executive at supply chain management company Imperial Logistics, considers the danger posed by fake an 7 September 2018
In an Expert View piece, Elisabethann Wright and Jane Summerfield, from law firm Hogan Lovells, look at some useful points to come out of the UK government rega 31 August 2018
In light of a report on the 10 most important medicines over the life of the UK's National Health Service NHS).the Association of the British Pharmaceutical Ind 24 August 2018
In an Expert View piece, Charlie Johnson, chief executive of UK biotech ADC Bio, takes a look at a product class that is still in its infancy. 16 August 2018
In an Expert View piece, Mark Davison, head of operations in the European Union for software company rfxcel, outlines everything marketing authorization holders 8 August 2018
In an Expert View piece, Doug Robinson, principal at IP firm Harness Dickey, considers some of the challenges facing the pharma industry in the field of patent 3 August 2018
The General Data Protection Regulation (GDPR) is a European Union regulation which came into force on May 25th 2018.In an exclusive Expert View piece for The Ph 25 July 2018
It’s been a rapid journey for the biopharma industry over the last few years. We’ve seen the industry stagger to its feet – surpassing notable early setbacks ca 20 July 2018
Andrew Rut, chief executive of MyMeds&Me, writes an Expert View piece on Japanese openings for tech-based pharmacovigilance firms in the wake of regulatory chan 12 July 2018
Guy Payette, president of Innomar Strategies and a former director at Boehringer Ingelheim, has more than 30 years experience in navigating the Canadian healthc 5 July 2018
Lynn Lewis is chief commercial officer at the contract research organisation (CRO) Envigo. She was appointed in 2017 following 15 years at the CRO Covance. In a 21 June 2018
Writing for The Pharma Letter, they seek to address the challenges posed to the existing biopharma business model by revolutionary, but prohibitively expensive, 13 June 2018
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.